Antibodies against pneumococcal polysaccharides after vaccination in HIV-infected individuals: 5-year follow-up of antibody concentrations

Citation
Fp. Kroon et al., Antibodies against pneumococcal polysaccharides after vaccination in HIV-infected individuals: 5-year follow-up of antibody concentrations, VACCINE, 18(5-6), 1999, pp. 524-530
Citations number
45
Categorie Soggetti
Veterinary Medicine/Animal Health",Immunology
Journal title
VACCINE
ISSN journal
0264410X → ACNP
Volume
18
Issue
5-6
Year of publication
1999
Pages
524 - 530
Database
ISI
SICI code
0264-410X(19991014)18:5-6<524:AAPPAV>2.0.ZU;2-A
Abstract
We studied the production of IgG antibodies against eight pneumococcal poly saccharide serotypes (PPS) 1, 4, 6B, 9V, 14, 18C, 19F and 23F after vaccina tion of 50 HIV-infected adults with 23-valent Pneumovaxa(R)23 and the cours e of the antibodies against four PPS during the following years. Mean antib ody concentrations against PPS 18C, 19F and 23F were sigificantly lower in the patients with CD4(+)-lymphocyte counts <200 x 10(6)/l than in healthy c ontrols; mean antibody concentrations against PPS 1, 4, 9V, 6B and 14 were similar in HIV-infected individuals and controls. Although it has been assu med that polysaccharides induce a T-cell-independent immune response, our r esults indicate that some PPS are T-cell-independent type 2 antigens. The r ates of decline of mean antibody concentrations in HIV-infected individuals and in healthy controls were similar during 5 y after vaccination. However , as a consequence of the low postvaccination antibody concentrations again st several PPS, within 3 y after vaccination most HIV-infected individuals had antibody concentrations below the level which is assumed to be required for protection. (C) 1999 Elsevier Science Ltd. All rights reserved.